Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Van Looveren RX, radiologie BV from Schilde, company number BE0735850611, closed financial year 2025 with a result of € 604,954 after tax. For that financial year Van Looveren RX, radiologie BV recorded a gross margin of € 832,531 and equity of € 100. Compared with financial year 2024, the result moved from € 616,123 to € 604,954. The company is profitable. The buffer shrank hard: equity is 100 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.
€ 100
▼ € 616,123 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 604,954
▼ 2% vs 2024
Profit after tax over the fiscal year.
€ 8,742
▼ 89% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.2 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 19,257
▲ 119% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 357
▼ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 16,008
▲ 23% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 707,073 | € 788,369 | € 833,063 | € 832,531 | |
| Profit after taxes | € 518,348 | € 584,491 | € 616,123 | € 604,954 | ▼ 2% |
| Equity | € 518,487 | € 584,591 | € 616,223 | € 100 | ▼ € 616,123 |
| Total debts | € 191,512 | € 242,352 | € 49,669 | € 610,813 | ▲ € 561,145 |
| Cash | € 203,578 | € 303,231 | € 80,600 | € 8,742 | ▼ 89% |
| Retained profit | € 518,387 | € 584,491 | € 616,123 | € 0 | ▼ 100% |
| Dividend | € 899,400 | € 518,387 | € 584,491 | € 1,221,077 | ▲ 109% |
| Bank debt | € 0 | € 0 | € 33,800 | € 0 | ▼ 100% |
| Balance sheet total | € 709,999 | € 826,943 | € 665,892 | € 610,913 | ▼ 8% |
Key figures of Van Looveren RX, radiologie BV, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Van Looveren RX, radiologie BV?
What happened at Van Looveren RX, radiologie BV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 604,954 (▼ 2% vs 2024). Source: NBB ↗
- New establishment in Schilde. KBO
- Kevin Van Looveren became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 518,348 profit in 2022 to € 604,954 profit in 2025.
Paid € 761,963 in corporate taxes since 2022.
Best year ever: 2024, with € 616,123 profit.
Paid out € 3.2 million in dividends to the owners in total.
Management
Behind Van Looveren RX, radiologie BV is Kevin Van Looveren. It owns 20% of Aveo Radiologie and 20% of Aveo Immo itself.
Directors
According to the 2025 annual accounts
Kevin Van Looveren
Director
since 2019
Establishments
Establishment units
Physical locations of this company
De Nachtegaal 42
2970 Schilde
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0735.850.611
- VAT number
- BE 0735.850.611
- Registered office
- De Nachtegaal 42, 2970 Schilde
- Names & denominations
- Van Looveren RX, radiologie BV · Van Looveren RX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 October 2019
- Peppol
- Active · Active since 27 Mar 2025